1040-8428
Monthly
No
CRIT REV ONCOL HEMAT
1983
175
UNITED STATES
偏慢,4-8周审稿时间
一般平均录用比例
5.6影响因子
血液学小学科
15/98JIF RANK
12056总被引频次
月期刊平台服务过的文章录用时间为1-3个月,依据20年经验,经月期刊专家预审通过后的文章,投稿通过率100%以上!
《肿瘤学/血液学评论》发表了由世界各地的专家撰写的关于肿瘤学和血液学所有领域的学术评论。所有自发邀请或提交的评审文章在最终验收前都要接受同行评审。《肿瘤学/血液学评论》是欧洲肿瘤学学院(ESO)的官方期刊。《肿瘤学/血液学评论》的编辑通常不会考虑提交前的询问。请参阅肿瘤学/血液学的目标和范围中的关键评论,以确保您的论文符合期刊的范围。有关提交手稿和编写手稿指南的更多信息,请参阅《作者指南》。
http://ees.elsevier.com/croh
Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world. All review articles, invited or submitted spontaneously, are subject to peer review before final acceptance. Critical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO).The Editors of Critical Reviews in )Oncology/Hematology will usually not consider pre-submission inquiries. Kindly refer to the Critical Reviews in Oncology/Hematology's Aims and Scope to ensure that your paper fits the journal's scope. Further information regarding the submission of manuscripts and guidelines for the preparation of the manuscripts can be found in the Guide for Authors.